C1s, Human, clone 10/12
Antibody 10/12 recognizes human activated C1s, a molecule of the complement C1 complex and hence part of the component that initializes classical pathway activation.
Read moreAntibody 10/12 recognizes human activated C1s, a molecule of the complement C1 complex and hence part of the component that initializes classical pathway activation.
Upon recognition of immune complexes by C1q, C1r is autoactivated and subsequently activates C1s, which is then able to cleave C4 and C2, leading to the formation of the C3 convertase and further activation of the terminal pathway of the complement system. C1s deficiencies are associated with impaired function of the classical complement pathway.
The zymogen form of C1s is a glycosylated single chain polypeptide with a MW of around 85kDa and the domain architecture CUB1-EGF-CUB2-CCP1-CCP2-SP, while activation through C1r leads to a 58kDa and a 27kDa chain, linked by disulfide bonds. Monoclonal antibody 10/12 is a murine IgG1 antibody directed against the CCP1-CCP2-SP domains of activated C1s and can detect human C1s in immunoassays.
W: Antibody 10/12 recognizes only the complex C1s-C1INH in western blot, both under reduced and non-reduced conditions. The expected band size is 150 - 196 kDa.
Calculate your ELISA data easily
With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.
Latest Hycult Biotech news
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
- NEW Human C3d ELISAWe are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which is not available in other C3 variants. This way it specifically distinguishes C3d from native C3… Read more: NEW Human C3d ELISA